What Morphing does

Morphing (legal entity Amorphous, Inc.) is a San Francisco-based enterprise AI company founded in 2021 by Tony Gaughan, Paul Buttle, and Luca Gibelli. The company sells an AI platform whose core concept is "Neurobots" — autonomous, self-learning atomic functions that connect to each other, to enterprise application data, and to human-facing AI agents to automate repetitive tasks and improve decision-making across enterprise technology environments. The platform is model-agnostic, integrates trusted information from 250+ standard enterprise applications, and combines that data with leading third-party foundational models while supporting fine-tuning and Reinforcement Learning from Human Feedback (RLHF).

The product portfolio consists of two components: Neurobots (the automation layer) and an Enterprise AI Architecture (the model-agnostic foundation). Underlying capabilities include structured-data integration, text-based interaction, multimodal agent coordination, process automation, knowledge retrieval across enterprise apps, and continuous optimization through observing user interactions.

The business operates on a SaaS subscription model delivered through a web application portal (app.morphing.ai), with enterprise deployments governed by a Master SaaS Agreement. Go-to-market is direct enterprise field sales targeting large organizations in finance, pharmaceuticals, and healthcare — verticals with high data governance and security requirements. The company has 1–10 employees, no disclosed funding rounds, no named customers, no public pricing, and no disclosed partnerships; it conducted its official product launch in 2024.

Name

Morphing

Legal name

Amorphous, Inc.

Website

https://morphing.ai

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Morphing, operating as Amorphous, Inc., is a San Francisco-based enterprise AI company that sells a model-agnostic platform built around proprietary Neurobots — autonomous, self-learning agents that automate enterprise workflows and integrate data from 250+ applications. It targets large organizations in finance, pharmaceuticals, and healthcare via direct enterprise sales.

Ownership category

akta.pro rank

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. SaaS/Enterprise Software Subscription: The company operates a SaaS model providing access to its proprietary products and related services through app.morphing.ai. Services are offered subject to Terms of Service or Master SaaS Agreement for enterprise customers. The platform appears to be subscription-based, though specific pricing tiers are not publicly disclosed.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Morphing AI sells an enterprise AI platform centered on Neurobots—autonomous, self-learning atomic functions that automate tasks, clean and unify data across 250+ enterprise applications, and integrate with leading foundational models through a model-agnostic architecture. The platform supports fine-tuning and RLHF, enforces corporate governance and security protocols, and is delivered as a SaaS solution under a Master SaaS Agreement to large enterprise customers in finance, pharmaceuticals, and healthcare.

Product overview

Morphing AI is an enterprise AI technology firm that offers a unified platform combining Neurobots (autonomous, self-learning agent systems) with an Enterprise AI Architecture. The product portfolio centers on Neurobots technology—atomic, autonomous functions that automate tasks, connect enterprise data sources, and evolve through observing user interactions and data. The Enterprise AI Architecture provides the foundational layer with model-agnostic capabilities, fine-tuning and RLHF features, and integration with 250+ standard applications. Together, these products enable organizations to automate repetitive enterprise operations, improve data quality and reliability, and generate strategic insights while maintaining corporate governance and security.

Differentiator

Problem solved

Functional benefit

Products and services

• Neurobots Neurobots are autonomous, self-learning atomic functions that automate and enhance tasks within enterprise technology environments for large organizations. They connect with each other, enterprise application data, and AI agents to adapt and evolve over time, handling repetitive work, cleaning and unifying data from multiple sources, and enforcing corporate governance and security measures.
• Enterprise AI Architecture An enterprise AI platform for large organizations that enhances AI models by combining enterprise data with leading foundational models, with a model-agnostic data logging system for real-time rewinding, replaying, and model switching. It supports fine-tuning and Reinforcement Learning from Human Feedback (RLHF), integrates trusted information from 250+ standard applications, and enforces corporate governance and security controls.

Quantifiable outcome

• Improved data accuracy and uniformity across enterprise information sources
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Scale indicators1 record

Recent moves3 records

Expansion highlights4 records

Emerging players

• Cognigy: Enterprise conversational and agentic AI platform focused on customer service automation across contact centers — overlapping use case space with Morphing's enterprise automation play, though with a stronger contact-center vertical emphasis.
• CrewAI: Multi-agent orchestration framework for building collaborative AI agent workflows — emerging player with a similar composable agent mental model to Morphing's Neurobots, but positioned more as a developer framework than a packaged enterprise product.
• Relevance AI: AI agent platform enabling enterprises to build and deploy autonomous agents across business workflows — an emerging competitor with overlapping agent-automation value proposition for enterprise customers.

Direct peers

• Aisera: AI agent platform for enterprise service management and automation, offering autonomous agents that integrate across enterprise systems — directly comparable to Morphing's Neurobot-based approach to task automation.
• Moveworks: Enterprise AI agent platform that automates tasks and workflows across IT, HR, and other business systems — the same core value proposition as Morphing's Neurobots, but with a much larger customer base and established enterprise distribution.
• Kore.ai: Enterprise conversational and agentic AI platform that automates workflows across business functions using composable AI agents — closely aligned with Morphing's autonomous agent architecture and enterprise focus.

Broad incumbents

• Automation Anywhere: Enterprise RPA and AI agent platform serving finance, healthcare, and other regulated industries — a comparable vertical focus and automation-first positioning, with substantially greater scale and capital.
• Salesforce (Agentforce / Einstein): Salesforce's Agentforce and Einstein platforms provide autonomous AI agents for CRM, sales, and service workflows — a comparable enterprise agent offering bundled into a broader platform with deep data integration across business apps.
• UiPath: Incumbent RPA and automation platform increasingly layering AI agents and document understanding onto its automation stack — comparable as an enterprise automation competitor, though Morphing's Neurobots emphasize autonomous learning versus UiPath's rule-based origin.
• Microsoft (Copilot & Copilot Studio): Microsoft Copilot and Copilot Studio offer enterprise-grade AI agents and automation across the Microsoft 365 and Azure ecosystem — the dominant broad incumbent Morphing must position against, with unmatched enterprise distribution and capital.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/morphing_ai
• LinkedInlinkedin.com/company/104199303

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Morphing